{"id":"W4327519976","doi":"10.2139/ssrn.4387512","title":"Single Ad26.COV2.S Booster Dose Following Two Doses of BBIBP-CorV Vaccine Against SARS-CoV-2 Infection in Adults: Day 28 Results of a Phase 1/2 Open-Label Trial","year":2023,"lang":"en","type":"article","venue":"SSRN Electronic Journal","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Immunogenicity; Medicine; Vaccination; Adverse effect; Antibody; Booster dose; Immunology; Virology; Neutralization; Immune system; Internal medicine; Titer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002058228,0.002753724,0.003965659,0.0005282812,0.0006618037,0.001496633,0.001299109,0.003270888,0.00494223],"category_scores_gemma":[0.001406245,0.0009386922,0.002213176,0.0003812394,0.001874495,0.001856978,0.0003645768,0.005094494,0.001971426],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001081935,"about_ca_system_score_gemma":0.001745033,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00161989,"about_ca_topic_score_gemma":0.002712646,"domain_scores_codex":[0.9991431,0.0003356828,0.00004105538,0.0001705352,0.00006739354,0.000242119],"domain_scores_gemma":[0.9990174,0.0002072068,0.0001566285,0.00009556956,0.00007799677,0.0004452468],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9215631,0.03465852,0.0006011208,0.0003927714,0.000507835,0.00005764772,0.0001328864,0.0007568135,0.009915982,0.0001253558,0.001718301,0.0295697],"study_design_scores_gemma":[0.6468022,0.3478685,0.002379612,0.00003285159,0.0002012135,0.00004407842,0.00003649712,0.0005840962,0.001102313,0.0001556073,0.0007640199,0.00002905772],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902802,0.002432374,0.0006597275,0.0006626123,0.0004677879,0.00257039,0.001184159,0.0001703302,0.001572483],"genre_scores_gemma":[0.9826555,0.002413193,0.001928366,0.0012381,0.0005666807,0.003544335,0.002125145,0.00006366039,0.005464937],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00494223,"threshold_uncertainty_score":0.01653343,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06305598116597597,"score_gpt":0.4016713254660222,"score_spread":0.3386153443000463,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}